These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12923983)

  • 1. Process validation: removing the magic, mystery, and mayhem.
    Ward AJ
    Biomed Instrum Technol; 2003; 37(4):292-4. PubMed ID: 12923983
    [No Abstract]   [Full Text] [Related]  

  • 2. How to kick-start your CAPA process.
    Peterson K
    Biomed Instrum Technol; 2005; 39(1):55-9. PubMed ID: 15742850
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrating risk management into the CAPA process.
    Bills E; Tartal J
    Biomed Instrum Technol; 2008; 42(6):466-8. PubMed ID: 19012461
    [No Abstract]   [Full Text] [Related]  

  • 4. Measure for measure: developing benchmarks for clinical engineering activities: a methodology.
    Gaev JA
    Biomed Instrum Technol; 2007; 41(4):267-77. PubMed ID: 17849749
    [No Abstract]   [Full Text] [Related]  

  • 5. The compatibility of standardisation and innovation.
    Moore R
    Med Device Technol; 2004 Nov; 15(9):28. PubMed ID: 16231785
    [No Abstract]   [Full Text] [Related]  

  • 6. Ask George.
    Biomed Instrum Technol; 2017; 51(3):185. PubMed ID: 28530867
    [No Abstract]   [Full Text] [Related]  

  • 7. Conducting clinical studies in Italy.
    Donawa M
    Med Device Technol; 2005 Oct; 16(8):21-4. PubMed ID: 16355966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is in the QSR/GMP?
    Bartoo G;
    IEEE Eng Med Biol Mag; 2004; 23(4):83-5. PubMed ID: 15508391
    [No Abstract]   [Full Text] [Related]  

  • 9. Using a Scientific Approach to Meet Joint Commission AEM Standards.
    Stern G
    Biomed Instrum Technol; 2017; 51(2):157-162. PubMed ID: 28296449
    [No Abstract]   [Full Text] [Related]  

  • 10. The IVD directive: late-phase practicalities.
    Johnson P; Walker R
    Med Device Technol; 2003 Nov; 14(9):35-6. PubMed ID: 14682022
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA flexes muscle in oversight of medical devices, technologies.
    Cruise C
    Biomed Instrum Technol; 2011; 45(2):105-8. PubMed ID: 21466325
    [No Abstract]   [Full Text] [Related]  

  • 12. The US medical device bundling policy.
    Donawa M
    Med Device Technol; 2004 Nov; 15(9):25-7. PubMed ID: 16231784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European medical device regulation: a new era?
    Donawa M
    Med Device Technol; 2004 Dec; 15(10):30-1. PubMed ID: 16225282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognizing the need for harmonized standards.
    Larrick K
    Biomed Instrum Technol; 2006; 40(2):164-5. PubMed ID: 16649484
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient protection at risk in IEC 60601-1 3rd edition.
    Dybdahl K;
    Med Device Technol; 2009 Sep; 20(5):26, 28-9. PubMed ID: 19852179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluations clinical investigations under the amended Medical Device Directive.
    Dannhorn DR; Schwabedissen H
    Med Device Technol; 2008 Sep; 19(5):16-8, 20. PubMed ID: 18947145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marketing a medical device without a 510(k).
    Munzner R
    IEEE Eng Med Biol Mag; 2003; 22(5):133. PubMed ID: 14699948
    [No Abstract]   [Full Text] [Related]  

  • 18. Reflections on the year.
    Neale M
    Med Device Technol; 2001 Dec; 12(10):28-9. PubMed ID: 15966142
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurotech report.
    Cavuoto J
    Neuromodulation; 2011; 14(6):492. PubMed ID: 22151502
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA pilot programme in support of global harmonisation.
    Donawa ME
    Med Device Technol; 2003 Nov; 14(9):32-4. PubMed ID: 14682021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.